Recently, the innovative product "Phakic Intraocular Lens" of Eyebright Medical Technology (Beijing) Co., Ltd. is approved by China NMPA.

This product is designed for the treatment of adults with a crystalline lens in the eye, specifically to correct or reduce myopia in adults ranging from -3.25D to -18.00D. It features a zero spherical aberration large optical zone and a double-concave design with stable arc height, which enhances visual quality and provides a wider peripheral arc height.

The NMPA will strengthen the post-marketing surveillance of the product to ensure the safe use of this medical device.